CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mridula George, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, United States
- Rwjbarnabas Health - Robert Wood Johnson University Hospital
Hamilton, New Jersey, United States
- Jersey City Medical Center
Jersey City, New Jersey, United States
- Monmouth Medical Center - Southern Campus
Lakewood, New Jersey, United States
- Cooperman Barnabas Medical Center
Livingston, New Jersey, United States
- Monmouth Medical Center
Long Branch, New Jersey, United States
- Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Robert Wood Johnson Barnabas Hospital -Somerset
Somerville, New Jersey, United States
- Steeplechase Cancer Center
Somerville, New Jersey, United States
- Monmouth Medical Center Vantage Point Infusion Cente
West Long Branch, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Apr 2022
- Primary completion
- 28 Nov 2027
- Completion
- 28 Nov 2027
- Last update posted
- 9 Feb 2026
- Registered enrollment
- 34
- Registry id
- NCT05333874
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.